Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization
- 31 August 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 32 (2), 311-319
- https://doi.org/10.1016/s0735-1097(98)00252-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- Bleeding Complications With the Chimeric Antibody to Platelet Glycoprotein IIb/IIIa Integrin in Patients Undergoing Percutaneous Coronary InterventionCirculation, 1995
- Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six monthsThe Lancet, 1994
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994
- Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA.Circulation, 1993
- Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Hemorrhagic Events during Therapy with Recombinant Tissue-Type Plasminogen Activator, Heparin, and Aspirin for Acute Myocardial InfarctionAnnals of Internal Medicine, 1991
- Thrombin activity induced by balloon angioplasty of the coronary artery in Macaca fascicularis (cynomolgus monkey)Blood Coagulation & Fibrinolysis, 1990
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988
- Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapyThe American Journal of Medicine, 1987